Philip Mease - Articles and news items


Brodalumab treatment improved clinical signs and symptoms in Phase 2 psoriatic arthritis study published in The New England Journal Of Medicine

Industry news / 12 June 2014 / Amgen

Phase 3 program underway to further assess Brodalumab as potential treatment for people living with psoriatic arthritis…

Abbott logo
Abbott logo

Abbott presents HUMIRA® (adalimumab) Phase 3 study results

Industry news, News / 7 November 2011 / Abbott

In ABILITY-1 Study Presented at ACR, More than Twice as Many Patients Treated with HUMIRA Met Primary Endpoint Compared to Placebo…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...